Lilly Stock Down 5% in a Month: Should You Buy Now or Steer Clear? [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
Shares of Eli Lilly and Company LLY have declined 5.2% in the past month despite the company reporting robust fourth-quarter 2025 results on Feb. 4. Industry pricing concerns, rising competitive pressure in the diabetes and obesity market and broader equity market corrections have led to downward pressure on shares. Rival Novo Nordisk NVO recently cut prices of its semaglutide medicines, Ozempic for diabetes and Wegovy for obesity. The price cuts by NVO triggered investor concerns that Lilly may also need to cut prices of its widely used GLP-1 therapies, Mounjaro, for type II diabetes, and Zepbound for obesity. There are also some concerns that the global obesity market may not be as large as the previous expectation of around $150 billion due to pricing and competitive pressures. The drop in Lilly's share price occurred after a very strong rally earlier, following the robust Q4 results and an optimistic guidance for 2026. So, should this be treated as a buying opportunity or a w
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- GLP-1 drugs linked to lower addiction risk, study finds [USA TODAY]USA TODAY
- GLP-1 Receptor Agonist (Trulicity, Wegovy, Ozempic, Mounjaro) Market Trends Analysis Report 2026 [Yahoo! Finance]Yahoo! Finance
- Third Annual Bio-IT World Venture, Innovation & Partnering Conference Returns to Boston May 19 [Yahoo! Finance]Yahoo! Finance
- Eli Lilly and Company (LLY) had its "overweight" rating reaffirmed by Morgan Stanley.MarketBeat
- Eli Lilly Expands Obesity Access As Oral GLP-1 Data Shape Growth Story [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 2/4/26 - Beat
LLY
Sec Filings
- 2/19/26 - Form 4
- 2/18/26 - Form 4
- 2/18/26 - Form 4
- LLY's page on the SEC website